MPLT- Maplight Therapeutics, Inc.

Name: Maplight Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Maplight Therapeutics, Inc. (MPLT) has 13 insiders with recent SEC Form 4 filings, including 5 buys and 24 sells. MPLT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Novo Holdings A/s	2.73M	$81.87M	-
CEO	Kroeger Christopher A.	1.39M	$41.76M	-
CFO	Setia Vishwas	387.8K	$11.62M	-
Dir	Malenka Robert C.	358.2K	$10.73M	-
Other	Foff Erin Pennock	346.1K	$10.36M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 18, 2026	Kroeger Christopher A.	Chief Executive Officer	Sell	118,235	$27.19	$3,214,999.73	-4.1%	-	-
May 11, 2026	Hanson Kristopher	General Counsel	Sell	13,917	$30.13	$419,263.08	-2.0%	-	-
May 11, 2026	Kroeger Christopher A.	Chief Executive Officer	Sell	68,491	$28.47	$1,949,634.12	-0.5%	-	-
May 7, 2026	Lillie James Woodruff	Chief Scientific Officer	Sell	721	$28.28	$20,389.88	-0.3%	-	-
May 7, 2026	Foff Erin Pennock	Chief Medical Officer	Sell	4,438	$28.54	$126,639.62	-0.6%	-	-
Feb 20, 2026	Pavlov George64	Director	Buy	25,000	$17.65	$441,167.58	+97.1%	+63.8%	-
Feb 3, 2026	Malenka Robert C.	Director	Sell	7,040	$18.02	$126,860.78	-1.0%	+79.4%	-
Jan 30, 2026	Malenka Robert C.	Director	Sell	34,398	$18.49	$635,857.22	-2.2%	+80.2%	-
Oct 28, 2025	Catalyst4, Inc.	10% Owner	Buy	5,441,176	$17.00	$92,499,992.00	+38.2%	+7.3%	-
Oct 28, 2025	Novo Holdings A/s58	10% Owner	Buy	952,941	$17.00	$16,199,997.00	+34.9%	+7.3%	-

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC